Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Diver (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), C. Micieli (Leicester, United Kingdom), M. Ramsheh (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom). Anti-DP effects on airway bacterial load in a phase 2a trial. 2182

Member's Comments

No comment yet.

Related content which might interest you: The effect of viruses on the airway microbiome and how these changes influence long-term respiratory outcome Source: International Congress 2015 – Mechanisms of virus-driven and host-defence immune responses in acute virus-induced asthma Year: 2015 Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: a randomised crossover trial Source: Eur Respir J, 53 (4) 1801793; 10.1183/13993003.01793-2018 Year: 2019 The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 A randomized trial to determine the effect of glycopyrrolate/formoterol on exercise tolerance in COPD: influence of dynamic hyperinflation and dead space ventilation. Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Effects of a home programme of airway clearance techniques on adventitious respiratory sounds in patients with bronchiectasis: a randomised controlled trial Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 COPD exacerbations in the phase 3 revefenacin clinical trial program Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018 Ozone exposure leads to changes in airway permeability, microbiota and metabolome: a randomised, double-blind, crossover trial Source: Eur Respir J, 56 (3) 2000165; 10.1183/13993003.00165-2020 Year: 2020 Results of a phase 2a clinical trial with a peptide inhibitor of MARCKS protein indicate improvement of indices of bronchitis and lung function in patients with COPD Source: Annual Congress 2011 - Novel mechanisms in COPD Year: 2011 Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device Source: Eur Respir J 2004; 24: Suppl. 48, 406s Year: 2004 Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Effect of the continuous positive airway pressure in apneic patients with resistant hypertension: results from the randomized controlled RHOOSAS study Source: International Congress 2017 – CPAP therapy Year: 2017 A randomized controlled trial of 4 weeks of airway clearance with oscillating positive end expiratory pressure device versus autogenic drainage in people with bronchiectasis Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002 Bacterial load in induced sputum from acute asthma (preliminary results) Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 Inhibition of P2X3 by MK-7264 reduces 24-hour cough frequency in a randomized, controlled, Phase 2b clinical trial Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020 Year: 2021 The impact of bacterial colonisation on airway inflammation in stable COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012